Products
Technologies
Applications
Services
Resources
Selection Guides
About
Platelet activating factor receptor Inhibitors (IC50, Ki)
Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
 | Apafant | IC50 | 40.0 [1], 50.0 [2], 200.0 [3] |
 | 2-[3-Methoxy-2-propoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]sulfonylethanol | IC50 | 6.0 [1] |
| 2-[3-Methoxy-2-propoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]sulfonylethanol | Ki | 3.2 [1], 6.0 [2], 6.1 [3], 6.3 [4] |
 | (2R,5R)-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5-trimethoxyphenyl)oxolane | IC50 | 13.0 [1] |
| (2R,5R)-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5-trimethoxyphenyl)oxolane | Ki | 9.0 [1], 14.3 [2] |
References
This online resource may be cited as follows
MLA | "Quest Database™ Platelet activating factor receptor Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 14 Dec. 2025, https://www.aatbio.com/data-sets/platelet-activating-factor-receptor-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 14). Quest Database™ Platelet activating factor receptor Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/platelet-activating-factor-receptor-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |